AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.4660
-0.0660 (-12.41%)
At close: Apr 4, 2025, 4:00 PM
0.4552
-0.0108 (-2.32%)
After-hours: Apr 4, 2025, 7:48 PM EST

AEON Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
42.01-384.63-52.56-55.64-32.91
Upgrade
Depreciation & Amortization
0.10.10.070-
Upgrade
Other Amortization
--0.331.980.83
Upgrade
Asset Writedown & Restructuring Costs
-348---
Upgrade
Loss (Gain) From Sale of Investments
-----0.35
Upgrade
Loss (Gain) on Equity Investments
----0.14
Upgrade
Stock-Based Compensation
6.2575.895.224.79
Upgrade
Other Operating Activities
-69.35-15.554.4118.5916.59
Upgrade
Change in Accounts Payable
2.52-4.596.61-0.90.67
Upgrade
Change in Other Net Operating Assets
-1.821.85-0.352.310.79
Upgrade
Operating Cash Flow
-20.29-47.83-35.58-28.43-9.46
Upgrade
Capital Expenditures
---0.31-0.17-
Upgrade
Divestitures
-----1.27
Upgrade
Investing Cash Flow
---0.31-0.17-1.27
Upgrade
Long-Term Debt Issued
151444.51525.41
Upgrade
Short-Term Debt Repaid
-----0.3
Upgrade
Long-Term Debt Repaid
---3.99--
Upgrade
Total Debt Repaid
---3.99--0.3
Upgrade
Net Debt Issued (Repaid)
151440.511525.11
Upgrade
Issuance of Common Stock
0.15----
Upgrade
Other Financing Activities
----1.44-0.54
Upgrade
Financing Cash Flow
15.151440.5113.5624.57
Upgrade
Net Cash Flow
-5.15-33.834.62-15.0413.84
Upgrade
Free Cash Flow
-20.29-47.83-35.89-28.6-9.46
Upgrade
Free Cash Flow Margin
-----375.74%
Upgrade
Free Cash Flow Per Share
-35.23-0.62-18.61-16.31-103.26
Upgrade
Levered Free Cash Flow
-10.3-25.48-16.79-14.85-2.94
Upgrade
Unlevered Free Cash Flow
-10.3-25.48-16.79-14.85-2.93
Upgrade
Change in Net Working Capital
-0.74-0.35-6.18-1.19-1.68
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q